A new clinical trial finds a "morning after" dose of a common antibiotic can greatly lower the chances of sexually transmitted bacterial infections in high-risk people.
Sure, ad-blocking software does a great job at blocking ads, but it also blocks useful features of our website. For the best site experience please disable your AdBlocker.
